» Articles » PMID: 28109084

MiR-5195-3p Inhibits Proliferation and Invasion of Human Bladder Cancer Cells by Directly Targeting Oncogene KLF5

Overview
Journal Oncol Res
Specialty Oncology
Date 2017 Jan 22
PMID 28109084
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

miRNAs play a key role in the carcinogenesis of many cancers, including bladder cancer. In the current study, the role of miR-5195-3p, a quite recently discovered and poorly studied miRNA, in the proliferation and invasion of human bladder cancer cells was investigated. Our data displayed that, compared with healthy volunteers (control) and SU-HUC-1 normal human bladder epithelial cells, miR-5195-3p was sharply downregulated in bladder cancer patients and five human bladder cancer cell lines. The oligo miR-5195-3p mimic or miR-5195-3p antagomir was subsequently transfected into both T24 and BIU-87 bladder cancer cell lines. The miR-5195-3p mimic robustly increased the miR-5195-3p expression level and distinctly reduced the proliferation and invasion of T24 and BIU-87 cells. In contrast, the miR-5195-3p antagomir had an opposite effect on miR-5195-3p expression, cell proliferation, and invasion. Our data from bioinformatic and luciferase reporter gene assays identified that miR-5195-3p targeted the mRNA 3'-UTR of Krüppel-like factor 5 (KLF5), which is a proven proto-oncogene in bladder cancer. miR-5195-3p sharply reduced KLF5 expression and suppressed the expression or activation of its several downstream genes that are kinases improving cell survival or promoting cell cycle regulators, including ERK1/2, VEGFA, and cyclin D1. In conclusion, miR-5195-3p suppressed proliferation and invasion of human bladder cancer cells via suppression of KLF5.

Citing Articles

MiR-5195-3p predicts clinical prognosis and represses colorectal cancer progression by targeting TLR4/MyD88 signaling.

Lv Y, Guo S, Jin L, Wang K, Li Y, Li H Cell Div. 2024; 19(1):29.

PMID: 39390599 PMC: 11468180. DOI: 10.1186/s13008-024-00133-x.


The role of KLF5 in gut microbiota and lung adenocarcinoma: unveiling programmed cell death pathways and prognostic biomarkers.

Fang Q, Xu M, Yao W, Wu R, Han R, Kawakita S Discov Oncol. 2024; 15(1):408.

PMID: 39235679 PMC: 11377401. DOI: 10.1007/s12672-024-01257-w.


MiR-5195-3p targets the PCBP2/PI3K/AKT pathway to inhibit melanoma cell proliferation and migration.

Yang B, Wu Y, Chen Y, Li Y, Wang J, Cha X Heliyon. 2023; 9(9):e19227.

PMID: 37662755 PMC: 10474410. DOI: 10.1016/j.heliyon.2023.e19227.


CircRUNX1 drives the malignant phenotypes of lung adenocarcinoma through mediating the miR-5195-3p/HMGB3 network.

Wang Y, Li H, Chen W, Huang X, Fan R, Xu M Gen Thorac Cardiovasc Surg. 2023; 72(3):164-175.

PMID: 37474742 DOI: 10.1007/s11748-023-01960-5.


MicroRNA-5195-3p mediated malignant biological behaviour of insulin-resistant liver cancer cells via SOX9 and TPM4.

Yan J, Xie B, Tian Y, An W, Peng Z, Liu Z BMC Cancer. 2023; 23(1):557.

PMID: 37328795 PMC: 10273698. DOI: 10.1186/s12885-023-11068-x.


References
1.
Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L . Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2006; 66(6 Suppl 1):4-34. DOI: 10.1016/j.urology.2005.07.062. View

2.
Tetreault M, Yang Y, Katz J . Krüppel-like factors in cancer. Nat Rev Cancer. 2013; 13(10):701-13. DOI: 10.1038/nrc3582. View

3.
Gao Y, Wu K, Chen Y, Zhou J, Du C, Shi Q . Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription. Oncotarget. 2015; 6(41):43791-805. PMC: 4791267. DOI: 10.18632/oncotarget.6101. View

4.
Tarapore R, Yang Y, Katz J . Restoring KLF5 in esophageal squamous cell cancer cells activates the JNK pathway leading to apoptosis and reduced cell survival. Neoplasia. 2013; 15(5):472-80. PMC: 3638350. DOI: 10.1593/neo.122126. View

5.
Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S . Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett. 2012; 328(2):353-61. DOI: 10.1016/j.canlet.2012.10.017. View